SFM
PNT

Sphera Funds Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Sphera Funds Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-952,642
Closed -$6.35M – 111
2023
Q3 		$6.35M Hold
952,642
– – 1.16% 31
2023
Q2 		$8.63M Hold
952,642
– – 1.35% 17
2023
Q1 		$6.93M Hold
952,642
– – 1.16% 28
2022
Q4 		$6.94M Sell
952,642
-100,200
-10% -$744K 1.49% 21
2022
Q3 		$8.14M Buy
+1,052,842
New +$8.94M 1.13% 24
2022
Q1 		– Sell
-592,592
Closed -$3.32M – 101
2021
Q4 		$3.32M Sell
592,592
-146,598
-20% -$1.1M 0.36% 65
2021
Q3 		$5.68M Sell
739,190
-270,307
-27% -$2.47M 0.48% 62
2021
Q2 		$10.4M Buy
1,009,497
+289,497
+40% +$2.94M 0.7% 41
2021
Q1 		$7.57M Buy
720,000
+700,000
+3,500% +$9.49M 0.58% 47
2020
Q4 		$279K Hold
20,000
– – 0.02% 107
2020
Q3 		$288K Buy
+20,000
New +$273K 0.03% 93

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Sphera Funds Management's PNT Position: Q4 2023 in Review

Sphera Funds Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 952,642 shares — an estimated $6.35M sold.

Sphera Funds Management first reported a position in PNT in Q3 2020 and held it in 11 quarters. The position peaked at $10.4M in Q2 2021. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Sphera Funds Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Sphera Funds Management sold 952,642 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $6.35M.
  • Sphera Funds Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Sphera Funds Management's POINT Biopharma Global Inc. Common Stock position peaked at $10.4M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Sphera Funds Management's 13F filing for Q4 2023, filed 14 Feb 2024.